Ligand Pharmaceuticals Incorporated (LGND) has a market capitalization of $4.63B and trades at $232.34. The 52-week range is 93.58-227.92.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 36.1, Earnings Per Share (EPS) of $6.44, annual revenue of $268.09M.
The stock has a beta of 1.00, operates in the Healthcare sector.
